Identification of FDA-Approved Drugs That Induce Heart Regeneration in Mammals

被引：0

作者：

Nguyen, Ngoc U. ^{[1
]}

Ahmed, Mahmoud S. ^{[1
]}

Nakada, Yuji ^{[2
]}

Hsu, Ching-Cheng ^{[1
]}

Farag, Ayman ^{[1
]}

Wang, Ping ^{[1
]}

Menendez-Montes, Ivan ^{[1
]}

Thet, Suwannee ^{[1
]}

Lam, Nicholas T. ^{[1
]}

Tomchick, Diana R. ^{[1
]}

Walcott, Gregory ^{[2
]}

Grishin, Nick V. ^{[1
]}

Zhang, Jianyi J. ^{[2
]}

Sadek, Hesham A. ^{[1
]}

机构：

[1] UT SouthWestern Med Ctr, Dallas, TX USA

[2] Univ Alabama Birmingham, Birmingham, AL USA

来源：

CIRCULATION RESEARCH | 2022年 / 131卷 / 12期

关键词：

Cardiac regeneration; Drug administration;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

19740

引用

页码：E171 / E171

页数：1

共 50 条

[21] A systematic analysis of FDA-approved anticancer drugs
Sun, Jingchun
Wei, Qiang
Zhou, Yubo
Wang, Jingqi
Liu, Qi
Xu, Hua
BMC SYSTEMS BIOLOGY, 2017, 11 : 27 - 43
[22] FDA-APPROVED DRUGS TO TREAT SLEEP DISORDERS
不详
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (10)
[23] Mini review: The FDA-approved prescription drugs that induce ovulation in women with ovulatory problems
Sun, Chunlei
Rong, Xi
Cai, Yongqin
Qiu, Song
Farzaneh, Maryam
DRUG DEVELOPMENT RESEARCH, 2020, 81 (07) : 815 - 822
[24] Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome
Politiek, Frouwkje A.
Turkenburg, Marjolein
Koster, Janet
Ofman, Rob
Waterham, Hans R.
JOURNAL OF INHERITED METABOLIC DISEASE, 2024, 47 (02) : 302 - 316
[25] Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae
Li, Tingting
Feng, Jie
Xiao, Shuzhen
Shi, Wanliang
Sullivan, David
Zhang, Ying
ANTIBIOTICS-BASEL, 2019, 8 (02):
[26] Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases
Deepak, R. N. V. Krishna
Abdullah, Ahmad
Talwar, Priti
Fan, Hao
Ravanan, Palaniyandi
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2018, 86 (11) : 1202 - 1210
[27] Pharmacogenomic characterization of US FDA-approved cytotoxic drugs
Peters, Eric J.
Motsinger-Reif, Alison
Havener, Tammy M.
Everitt, Lorraine
Hardison, Nicholas E.
Watson, Venita G.
Wagner, Michael
Richards, Kristy L.
Province, Mike A.
McLeod, Howard L.
PHARMACOGENOMICS, 2011, 12 (10) : 1407 - 1415
[28] Repurposing FDA-approved drugs as potential PARP inhibitors
Eznarriaga, Maria
Rahman, Taufiq
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2516 - 2516
[29] RNA as an off-target for FDA-approved drugs
Fullenkamp, Christopher R.
Schneekloth, John S.
NATURE CHEMISTRY, 2023, 15 (10) : 1329 - 1331
[30] Pharmacogenetic Labeling of FDA-Approved Drugs A Regulatory Retrospective
Drozda, Katarzyna
Pacanowski, Michael A.
Grimstein, Christian
Zineh, Issam
JACC-BASIC TO TRANSLATIONAL SCIENCE, 2018, 3 (04): : 545 - 549

← 1 2 3 4 5 →